Market Overview:
The global human mycoplasma nucleic acid detection kit market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of mycoplasma infections, rising demand for nucleic acid detection kits for diagnosis and research applications, and technological advancements in nucleic acid detection kits. Based on type, the global human mycoplasma nucleic acid detection kit market can be segmented into DNA, RNA, and DNA/RNA. The DNA segment is expected to account for the largest share of the global human mycoplasma nucleic acid detection kit market in 2018. This segment is projected to grow at a CAGR of 7.8% during the forecast period from 2018 to 2030.
Product Definition:
A kit for the detection of human mycoplasma nucleic acid in clinical specimens. The importance of this kit is that it can help to diagnose and treat infections caused by human mycoplasma bacteria.
DNA:
DNA, it's usage and growth factor in Human Mycoplasma Nucleic Acid Detection Kit market is expected to witness significant growth over the forecast period. The primary drivers for this market are increasing prevalence of infectious diseases such as HIV-AIDS, Hepatitis B & C and many more. Moreover, growing awareness about DNA extraction from blood samples for testing purposes is also a key driver attributing to the rapid growth of this market.
RNA:
RNA is a nucleic acid that acts as a intermediate molecule during the synthesis of DNA. It plays an important role in various cellular processes such as gene expression, genetic silencing, and protein modification. In addition, RNA also has several non-cellular functions including regulation of the immune system and catalysis. The detection of mycoplasma infection using RT-PCR can be done with the help of this kit which helps in quantification from 2 to 100 nM for M.
Application Insights:
Diagnosis segment held the largest market share in 2017. This is due to the increasing prevalence of diseases associated with mycoplasma such as respiratory infections, tuberculosis, and urea cycle disorders. For instance, according to a study published by NCBI in 2018, around 60% of children suffering from acute lymphoblastic leukemia were found to be positive for mycoplasma infection during chemotherapy. Thus rising prevalence of chronic diseases increases demand for diagnosis kits which is anticipated to drive growth over the forecast period.
Research segment is expected register significant growth over the forecast period owing to increased government funding towards research related towards human mycoplasma nucleic acid detection kit market development along with other diagnostic tests used against HIV-1 and hepatitis viruses among others). For instance; MycoDx PGM (R&D Systems), an automated DNA/RNA amplification system that aids in rapid detection of MNGIEs has been developed by R&D Systems Corporation) Ltd.
Regional Analysis:
North America dominated the global market in 2017. This is due to the presence of a large number of research laboratories and diagnostic centers that use mycoplasma detection techniques for various applications. Moreover, increasing prevalence of chronic diseases such as cancer, respiratory infections, and autoimmune disorders drives the demand for these tests in this region.
Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to rising investments by leading players in this region along with continuous technological advancements. In addition, growing awareness about early diagnosis among patients will drive regional growth during the forecast period.
Growth Factors:
- Increasing demand for nucleic acid detection kits in research laboratories for the detection of human mycoplasma
- Growing prevalence of human mycoplasma infections
- Rising number of clinical trials for the development of new drugs and therapies for human mycoplasma infections
- Technological advancements in nucleic acid detection kits that offer enhanced performance and accuracy
- increasing funding by government and private organizations for research on human mycoplasma infections
Scope Of The Report
Report Attributes
Report Details
Report Title
Human Mycoplasma Nucleic Acid Detection Kit Market Research Report
By Type
DNA, RNA, DNA/RNA
By Application
Diagnosis, Research
By Companies
Liferiver, Sansure, Bioperfectus, Hybribio
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
151
Number of Tables & Figures
106
Customization Available
Yes, the report can be customized as per your need.
Global Human Mycoplasma Nucleic Acid Detection Kit Market Report Segments:
The global Human Mycoplasma Nucleic Acid Detection Kit market is segmented on the basis of:
Types
DNA, RNA, DNA/RNA
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Diagnosis, Research
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Liferiver
- Sansure
- Bioperfectus
- Hybribio
Highlights of The Human Mycoplasma Nucleic Acid Detection Kit Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- DNA
- RNA
- DNA/RNA
- By Application:
- Diagnosis
- Research
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Human Mycoplasma Nucleic Acid Detection Kit Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The Human Mycoplasma Nucleic Acid Detection Kit is a test that can be used to determine the presence of human mycoplasma DNA in a sample.
Some of the major players in the human mycoplasma nucleic acid detection kit market are Liferiver, Sansure, Bioperfectus, Hybribio.
The human mycoplasma nucleic acid detection kit market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Human Mycoplasma Nucleic Acid Detection Kit Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Human Mycoplasma Nucleic Acid Detection Kit Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Human Mycoplasma Nucleic Acid Detection Kit Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Human Mycoplasma Nucleic Acid Detection Kit Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Human Mycoplasma Nucleic Acid Detection Kit Market Size & Forecast, 2020-2028
4.5.1 Human Mycoplasma Nucleic Acid Detection Kit Market Size and Y-o-Y Growth
4.5.2 Human Mycoplasma Nucleic Acid Detection Kit Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 DNA
5.2.2 RNA
5.2.3 DNA/RNA
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Diagnosis
6.2.2 Research
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Human Mycoplasma Nucleic Acid Detection Kit Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Human Mycoplasma Nucleic Acid Detection Kit Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 DNA
9.6.2 RNA
9.6.3 DNA/RNA
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Diagnosis
9.10.2 Research
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 DNA
10.6.2 RNA
10.6.3 DNA/RNA
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Diagnosis
10.10.2 Research
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 DNA
11.6.2 RNA
11.6.3 DNA/RNA
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Diagnosis
11.10.2 Research
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 DNA
12.6.2 RNA
12.6.3 DNA/RNA
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Diagnosis
12.10.2 Research
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 DNA
13.6.2 RNA
13.6.3 DNA/RNA
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Diagnosis
13.10.2 Research
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Human Mycoplasma Nucleic Acid Detection Kit Market: Competitive Dashboard
14.2 Global Human Mycoplasma Nucleic Acid Detection Kit Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Liferiver
14.3.2 Sansure
14.3.3 Bioperfectus
14.3.4 Hybribio
